Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
About this item
Full title
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Author / Creator
Publisher
Boston: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2020-09, Vol.383 (11), p.1050-1056
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Amphetamines and methylphenidate and, less often, nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD. Inattentiveness and restlessness are improved more than quality-of-life measures in short-term trials.
Alternative Titles
Full title
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2441297922
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2441297922
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMra1917069
How to access this item
Log in as a Library member
